(Q41028439)

25 September 2017

Is there complete cross-resistance of gram-negative bacilli to gentamicin and tobramycin? (English)

1 reference

25 September 2017

Gram-negative bacteria

0 references

gentamicin

0 references

author name string

Crowe CC

series ordinal

1

1 reference

25 September 2017

Sanders E

series ordinal

2

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 November 1972

1 reference

Antimicrobial Agents and Chemotherapy

25 September 2017

1 reference

25 September 2017

2

1 reference

25 September 2017

5

1 reference

25 September 2017

415-416

1 reference

Cross-Resistance of Pseudomonas to Gentamicin and Tobramycin

25 September 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444330

Evaluation of the in vitro activity of tobramycin as compared with that of gentamicin sulfate

26 September 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444330

Preliminary studies with nebramycin factor 6

26 September 2017

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/4670511

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Structure of nebramycin factor 6, a new aminoglycosidic antibiotic

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/4670511

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.2.5.415

1 reference

25 September 2017

1 reference

25 September 2017

PubMed publication ID

4670511

1 reference